{"entity":{"type":"insider","cik":"0001742587","url":"/insider/0001742587","json_url":"/insider/0001742587.json","name":"Sinha Uma","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":9,"first":"2019-05-28","last":"2021-01-15","span_basis":"filed_date"},"name_variants":[{"name":"Sinha Uma","source":"filing","n_filings":9,"first_seen":"2019-05-28","last_seen":"2021-01-15"}],"transactions":[{"id":4707384,"accession":"0000899243-21-002179","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-002179","line_url":"/filing/0000899243-21-002179","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001742587","owner_name":"Sinha Uma","owner_display_name":"Sinha Uma","owner_url":"/insider/0001742587","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":124.31788532,"price_display":"124.32","price_state":"stated","total_value":1243178.8532,"total_display":"1,243,178.85","total_whole":"1,243,179","shares_owned_after":308825.0,"shares_owned_after_display":"308,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-13","filed_date":"2021-01-15","scope":"insider","n_lines":6},{"id":3167822,"accession":"0000899243-20-032771","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-032771","line_url":"/filing/0000899243-20-032771","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001742587","owner_name":"Sinha Uma","owner_display_name":"Sinha Uma","owner_url":"/insider/0001742587","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":90.03744088,"price_display":"90.04","price_state":"stated","total_value":450187.2044,"total_display":"450,187.20","total_whole":"450,187","shares_owned_after":317727.0,"shares_owned_after_display":"317,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-02","filed_date":"2020-12-04","scope":"insider","n_lines":4},{"id":2208541,"accession":"0000899243-20-029938","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-029938","line_url":"/filing/0000899243-20-029938","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001742587","owner_name":"Sinha Uma","owner_display_name":"Sinha Uma","owner_url":"/insider/0001742587","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":72.419808,"price_display":"72.42","price_state":"stated","total_value":362099.04,"total_display":"362,099.04","total_whole":"362,099","shares_owned_after":321525.0,"shares_owned_after_display":"321,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-29","filed_date":"2020-10-30","scope":"insider","n_lines":2},{"id":2684875,"accession":"0000899243-20-026974","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-026974","line_url":"/filing/0000899243-20-026974#line-3","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001742587","owner_name":"Sinha Uma","owner_display_name":"Sinha Uma","owner_url":"/insider/0001742587","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4831.0,"shares_display":"4,831","price_per_share":52.3542,"price_display":"52.35","price_state":"stated","total_value":252923.1402,"total_display":"252,923.14","total_whole":"252,923","shares_owned_after":326525.0,"shares_owned_after_display":"326,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-02","scope":"insider"},{"id":2684872,"accession":"0000899243-20-026974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-026974","line_url":"/filing/0000899243-20-026974","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001742587","owner_name":"Sinha Uma","owner_display_name":"Sinha Uma","owner_url":"/insider/0001742587","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":169.0,"shares_display":"169","price_per_share":52.032662721893495,"price_display":"52.03","price_state":"stated","total_value":8793.52,"total_display":"8,793.52","total_whole":"8,794","shares_owned_after":331356.0,"shares_owned_after_display":"331,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-30","filed_date":"2020-10-02","scope":"insider","n_lines":2},{"id":7910219,"accession":"0000899243-19-029765","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-029765","line_url":"/filing/0000899243-19-029765","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001742587","owner_name":"Sinha Uma","owner_display_name":"Sinha Uma","owner_url":"/insider/0001742587","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":61.903482152,"price_display":"61.90","price_state":"stated","total_value":773793.5269,"total_display":"773,793.53","total_whole":"773,794","shares_owned_after":333608.0,"shares_owned_after_display":"333,608","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-20","scope":"insider","n_lines":3},{"id":8091696,"accession":"0000899243-19-024339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-024339","line_url":"/filing/0000899243-19-024339","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001742587","owner_name":"Sinha Uma","owner_display_name":"Sinha Uma","owner_url":"/insider/0001742587","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":38.406576,"price_display":"38.41","price_state":"stated","total_value":96016.44,"total_display":"96,016.44","total_whole":"96,016","shares_owned_after":343681.0,"shares_owned_after_display":"343,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-25","filed_date":"2019-09-27","scope":"insider","n_lines":2},{"id":8225028,"accession":"0000899243-19-020520","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-19-020520","line_url":"/filing/0000899243-19-020520","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001742587","owner_name":"Sinha Uma","owner_display_name":"Sinha Uma","owner_url":"/insider/0001742587","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":36.12542502,"price_display":"36.13","price_state":"stated","total_value":180627.1251,"total_display":"180,627.13","total_whole":"180,627","shares_owned_after":348114.0,"shares_owned_after_display":"348,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-25","filed_date":"2019-07-29","scope":"insider","n_lines":4},{"id":8471979,"accession":"0000899243-19-019150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-019150","line_url":"/filing/0000899243-19-019150#line-1","is_derivative":false,"issuer_cik":"0001742587","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001742587","owner_cik":"0001742587","owner_name":"Sinha Uma","owner_display_name":"Sinha Uma","owner_url":"/insider/0001742587","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14000.0,"shares_display":"14,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":238000.0,"total_display":"238,000.00","total_whole":"238,000","shares_owned_after":14000.0,"shares_owned_after_display":"14,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-03","scope":"insider"},{"id":8306091,"accession":"0000899243-19-014838","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-014838","line_url":"/filing/0000899243-19-014838","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001742587","owner_name":"Sinha Uma","owner_display_name":"Sinha Uma","owner_url":"/insider/0001742587","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":27.2752,"price_display":"27.28","price_state":"stated","total_value":136376.0,"total_display":"136,376.00","total_whole":"136,376","shares_owned_after":350112.0,"shares_owned_after_display":"350,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-23","filed_date":"2019-05-28","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001731831","name":"Eidos Therapeutics, Inc.","url":"/issuer/0001731831","role":"Director, Officer (Chief Scientific Officer)","n_filings":8,"first_seen":"2019-05-28","last_seen":"2021-01-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001743881","name":"BridgeBio Pharma, Inc.","url":"/issuer/0001743881","role":"Officer (Chief Scientific Officer)","n_filings":1,"first_seen":"2019-07-03","last_seen":"2019-07-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001742587","retrieved_at":"2026-08-23T00:35:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}